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Metacarpophalangeal implant surgery: time
for a randomized clinical trial? Comment
on the article by Chung et al
To the Editor
I read with interest the study on long-term outcome of
silicone metacarpophalangeal implant surgery published
recently in Arthritis Care & Research (Chung KC, Burns
PB, Kim HM, Burke FD, Wilgis EF, Fox DA. Long-term
followup for rheumatoid arthritis patients in a multicenter
outcomes study of silicone metacarpophalangeal joint ar-
throplasty. Arthritis Care Res [Hoboken] 2012;64:1292–
300). The study was large, had a long-term followup pe-
riod, and included a comparator group. However, I have
some issues with the analysis strategy used by the authors
and their subsequent conclusions.
Because this study is not a randomized trial, the com-
parison between the groups must be made with great cau-
tion. Clearly at baseline, the patients who elected to have
surgery had much worse hand function (in all aspects
measured) than patients who declined surgery. The im-
provement in the surgery group is notable and contrasts
with the stable course in the control group. However, in
my view, the key ﬁnding is not (as reported) the difference
in change between the groups, but the fact that the surgery
group was able to improve to the level of the control group.
It would be interesting to learn the results of surgery
performed in the subgroup of patients with hand function
as good as the nonsurgery group at baseline. Did the pa-
tients in this subgroup show as much improvement as the
patients with worse hand function? Also, the decrease in
improvement over time suggests that a stable state was not
reached and the surgery group needed to be followed up
for even longer.
Finally, the analysis comparing the outcomes of the
study (surgical) hand with the contralateral (nonsurgical)
hand was unfortunately only brieﬂy described and shown
in a supplementary table. I think this analysis has greater
validity than the main analysis because the variability
between the hands of one patient is likely to be less than
the variability between the hands of separate patients. For
instance, the contralateral hand is more likely to also show
poor function and thus more resemble the surgical hand.
Also, the inﬂuences working at the patient level are likely
the same in both hands. Supplementary Table 1 of the
article did not show the baseline data for the nonsurgical
hand; however, it did show that the surgical hand im-
proved or maintained function better than the control
hand, conﬁrming the main study ﬁndings. Interestingly,
the supplementary table also conﬁrmed a ﬁnding not high-
lighted by the authors. In the main analysis, grip strength
was, not unexpectedly, less at baseline in the hands of the
surgical group compared to the hands of the control group.
However, grip strength increased more in the control
group than in the surgical group, and this was mirrored in
the within-patient analysis; namely, grip strength in-
creased in both hands, but more in the nonsurgical hands
than in the surgical hands (P  0.06).
In conclusion, this study adds to our knowledge of the
pros and cons of silicone implant surgery. Readers should
certainly look at Supplementary Table 1. Overall, I think
there is enough equipoise to perform a randomized trial on
the balance of beneﬁt and harm of this procedure.
Maarten Boers, MSc, MD, PhD
VU University Medical Center
Amsterdam, The Netherlands
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Reply
To the Editor:
We appreciate the comments by Dr. Boers about our
article and his interest in our research. Although the orig-
inal intent for our study of the outcomes following silicone
metacarpophalangeal arthroplasty (SMPA) was to perform
a randomized controlled trial (RCT), we found this ap-
proach was not feasible. Because of strong patient prefer-
ences, the likelihood of meeting our enrollment quota in
an RCT would have been seriously compromised. Addi-
tionally, there is the ethical decision to consider when
randomizing patients with rheumatoid arthritis who pres-
ent with severe deformities but have a high level of func-
tion. Whether this type of rheumatoid arthritis patient
should have surgery is questionable.
We agree that this cohort should be followed up for a
longer period to document the outcomes over time. To
facilitate this, we have received additional funding from
the National Institute of Arthritis and Musculoskeletal and
Skin Diseases and will follow this group for an additional
4 years, bringing our total followup time for this cohort to
7 years. The ﬁrst 3 years of the study have provided valu-
able results and we expect that this further followup will
do likewise.
Dr. Boers also indicated that it would be interesting to
learn the results of surgery on the subgroup of patients
who had hand function as good as the nonsurgery group
at baseline. First, although the control patients showed
higher function on average, for most measures, the ranges
of the control patients were wider than the ranges of the
SMPA patients. For example, the overall Michigan Hand
Outcomes Questionnaire (MHQ) scores at baseline ranged
from 3–96 in non-SMPA patients, whereas the scores ranged
from 10–84 in SMPA patients after surgery. Similarly, the
range for grip strength in the study hands was 0–34.7 in
the non-SMPA group and 0–28.3 in SMPA group.
Second, our propensity-stratiﬁed estimate was based on
a similar statistical approach to such a subgroup analysis
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in which we estimated between-group 3-year outcomes
after trimming patients in nonoverlapping propensity re-
gions. The propensities for receiving the operation were
estimated using a logistic regression model with various
baseline patient characteristics including baseline values
of various outcome measures. Therefore, trimming pa-
tients in nonoverlapping regions of propensity essentially
excluded patients who were not comparable at baseline.
After trimming, this analysis used a smaller subset of 59
patients whose propensities for receiving the operation
were comparable. As reported in the article, the propensi-
ty-stratiﬁed estimate for the 3-year overall summary score
was 14.8 points higher in the SMPA patients than in non-
SMPA patients, showing that in patients whose propensi-
ties for receiving the operation were similar, a signiﬁcant
improvement was expected in the SMPA group compared
with the non-SMPA group based on MHQ scores.
Last, Dr. Boers commented on the data in Supplemen-
tary Table 1 of our article that compared the change in
mean values for outcome variables in the surgical hand
and the control hand. This within-person comparison con-
trolled for the baseline difference noted in the surgical and
nonsurgical groups to some extent. However, subjects
could pick which hand would receive surgery and the
study hand was often worse in appearance and function
than the control hand. For example, overall mean baseline
MHQ scores were 48 for unoperated hands and 37 for
operated hands in the SMPA group and 61 for unoperated
hands and 56 for operated hands in the non-SMPA group.
Although not statistically signiﬁcant, it is not clear why
grip strength increased more in the control group than in
the surgical group or, similarly, why grip strength increased
more in control hands than in surgical hands in SMPA
patients. However, these results highlight the importance
of patient-reported outcomes over physical measures such
as grip strength in assessing outcomes following surgery.
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Assessment of hand involvement in
systemic sclerosis by ultrasonography:
comment on the article by Elhai et al
To the Editor:
We read with great interest the article by Elhai et al on
the potential role of ultrasonography (US) in the assess-
ment of hand involvement in systemic sclerosis (SSc) pub-
lished recently in Arthritis Care & Research (1). During
the course of their disease, SSc patients often experience
skeletal hand involvement, which is primarily assessed
by clinical examination and radiographs. As the authors
noted, skeletal hand involvement is underestimated in
SSc, thus supporting the potential role of US in the assess-
ment of hand involvement in SSc. The data provided by
Elhai et al are in agreement with previous reports (2–4)
showing the complementary role of US in assessing the
broad spectrum of hand conditions in SSc patients, par-
ticularly synovitis and tenosynovitis.
Regarding inﬂammatory joint involvement, the authors
described in depth the clinical aspects (i.e., swollen and
tender joints), the US ﬁndings (i.e., the distribution and
activity of synovitis), and the radiologic ﬁndings (i.e., dis-
tribution of joint space narrowing and erosions) even if
these aspects were studied singularly. Considering the dif-
ferent features of hand involvement, it would be of great
interest to classify these ﬁndings as previously reported by
the same authors as patterns rather than single aspects (5).
It is worth commenting on the observations made by the
authors regarding ﬁbrotic US tenosynovitis and its associ-
ation with the detection of tendon friction rubs (TFRs).
Previous studies on this topic have also revealed that
thickening of the A1 pulley, an increased thickness of the
retinacula by US (4,6,7), and connective tissue inﬁltrates
by magnetic resonance imaging might correspond to the
anatomic substrate of TFRs and be a hallmark of a more
severe connective tissue involvement in SSc patients. All
of the ﬁndings by Elhai et al were so closely associated
with TFRs to suggest that this was the lesion underlying
the sign (8).
Francesca Ingegnoli, MD
University of Milan
Milan, Italy
Giovanna Cuomo, MD
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